Several species of bacteria and fungi were found living in the central nervous system (CNS) of patients with amyotrophic lateral sclerosis (ALS) that could potentially be related to the development of the disease, a study reports. However, according to the researchers, more studies are still needed to confirm if…
News
A specific type of supporting cells called Schwann cells protect against nerve degeneration induced by the blood-clotting protein thrombin, according to new research in mice. Researchers say the findings could have implications for treatment development in amyotrophic lateral sclerosis (ALS), multiple sclerosis, and Alzheimer’s. The study, “…
Biochemist Dorothee Dormann, PhD, at the Ludwig Maximilians University, in Munich, was awarded the 2019 Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers for her groundbreaking work showing that amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share common underlying processes that drive disease development.
Higher levels of apathy — particularly its behavioral symptoms — in people with amyotrophic lateral sclerosis (ALS) are associated with a degree of greater burden for caregivers, according to a new study. The research, “The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis,”…
Madeline Collin, a 24-year-old activist with Gaucher disease, worries that patients like her will suffer deeply if Britain leaves the European Union (EU), as scheduled, at the end of this month. Collin is an expert on the subject. For her University of Bath dissertation, she analyzed Brexit’s long-term…
A magnetic resonance imaging (MRI) marker may facilitate amyotrophic lateral sclerosis (ALS) patients’ diagnosis and disease monitoring, a study finds. The study, “Is the Hypointensity in Motor Cortex the Hallmark of Amyotrophic Lateral Sclerosis?,” was published in the Canadian Journal of Neurological Sciences. ALS is a progressive neurological…
Occupational exposure to silica is linked to a significantly increased risk of amyotrophic lateral sclerosis (ALS), a population-based study suggests. The study “Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk” was published in the Journal of Neurology, Neurosurgery, and Psychiatry. The cause of…
Stem cell therapy using a certain type of stem cell called human mesenchymal stromal cells (hMSCs) may have the potential to improve outcomes and prevent progression of familial amyotrophic lateral sclerosis (ALS), a mouse study suggests. Repeated administrations of these stem cells in the spinal cord prolonged the lifespan…
With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn screening, to vaccinations, gene therapies and euthanasia. But rare diseases and the expensive therapies needed to treat them — particularly in an age of scarce economic resources — almost always entail “tragic choices,” warned Avraham Steinberg,…
Markers of oxidative stress, iron metabolism in the brain and nerve cell damage may accurately predict disability in patients with amyotrophic lateral sclerosis (ALS), according to new research. The study, “A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis,” appeared in the journal Scientific…
Recent Posts
- When an ALS caregiver takes a much-needed break from the daily routine
- Advocates push for swift passage of ACT for ALS reauthorization bill
- How to not get angry when trying to force a square peg into a round hole
- Shionogi completes acquisition of rights to ALS drug Radicava
- New rare gene variants tied to ALS risk in large international genetic analysis